PART I ETHICS IN CLINICAL PRACTICE 1 Bruce L. Miller (1981), 'Autonomy and the Refusal of Lifesaving Treatment', Hastings Center Report, 11, pp. 22-28. 2 David Degrazia (1995), 'Value Theory and the Best Interests Standard', Bioethics, 9, pp. 50-61. 3 Onora O'Neill (1984), 'Paternalism and Partial Autonomy', Jow/v/o/ ofMedical Ethics, 10, pp. 173-78. 4 Steve Clarke and Justin Oakley (2004), 'Informed Consent and Surgeons' Performance', Journal of Medicine and Philosophy, 29, pp. 11-35. 5 Robert M. Veatch (1972) 'Models for Ethical Medicine in a Revolutionaiy Age', Hastings Center Report, 2, pp. 5-7. 6 John Hardwig (1990), 'What about the Family?', Hastings Center Report, 20, pp. 5-10. 7 Rebecca Dresser (1995), 'Dworkin on Dementia: Elegant Theory, Questionable Policy', Hastings Center Report, 25, pp. 32-38. 8 Norman Daniels (1986), 'Why Saying No to Patients in the United States is So Hard: Cost Containment, Justice, and Provider Autonomy', New England Journal ofMedicme,i' \A, pp. 1380-83. PART II ISSUES AT THE OUTSET OF LIFE 9 Joseph Fletcher (1972), 'Indicators of Humanhood: A Tentative Profile of Man', Hastings Center Report, 2, pp. 1—4. 10 Stephen Buckle (1988), 'Arguing fi"om Potential', Bioethics, 2, pp. 227-53. 11 Jim Stone (1987), 'Why Potentiality Matters', Canadian Journal of Philosophy, 17, pp. 815-30. 12 Rosalind Hursthouse (1991), 'Virtue Theory and Abortion', Philosophy and Public Affairs, 20, pp. 223-46. ^ _ 13 Soren Holm (2002), 'G6irtg to the Roots of the Stem Cell Controversy', Bioethics, 16, pp. 493—507. 14 John Harris (1997), "'Goodbye Dolly?" The Ethics of Human Cloning', Journal of Medical Efi'''-s, 23, pp. 353—60. PART III REPRODUCTIVE ETHICS 15 Dena S. Davis (1997), 'Genetic Dilemmas and the Child's Right to an Open Future', Hastings Center Report, 27, pp. 7-15. 16 Julian Savulescu (2001), 'Procreative Beneficence: Why We Should Select the Best Children'. Bioethics, 15, pp. 413-26. 17 Michael J. Sandel (2004), 'The Case Against Perfection*, The Atlantic Monthly, 293, pp. 51-62. 18 Stephen Wilkinson (2003), 'The Exploitation Argument Against Commercial Surrogacy', Bioethics, 17, pp. 169-87. PART IV END-OF-LIFE ISSUES 19 Peter Singer (1995), 'Presidential Address: Is the Sanctity of Life Ethic Terminally ill?', Bioethics, 9, pp. 327^3. 20 Helga Kuhse (1984), 'A Modern Myth. That Letting Die is not the Intentional Causation of Death: Some Reflections on the Trial and Acquittal of Dr Leonard Arthur', Journal of Applied Philosophy, I, pp. 21 -38. 21 Margaret Pabst Battin (2005), 'Euthanasia: The Way We Do it, the Way They Do It', in Margaret Pabst Battin, Ending Life: Ethics and the Way We Die, Oxford: Oxford University Press (US), pp. 47-68. 22 George J. Annas (2005), '"Culture of Life" Politics at the Bedside - the Case of Terri Schiavo', New England Journal of Medicine, 352, pp. 1710-15. 23 JeffMcMahan (1988), 'Death and the Value of Life", Ethics, 99, pp. 32-61. PART V PROFESSIONAL INTEGRITY AND THE GOALS OF MEDICINE 24 Larry R. Churchill (1989), 'Reviving a Distinctive Medical Ethic', Hastings Center Report, 19, pp. 28-34. 25 Leon R. Kass (1989), 'Neither for Love nor Money: Why Doctors must not Kill', The Public Interest, 94, pp. 25-46. 26 Franklin G. Miller and Howard Brody (1995), 'Professional Integrity and Physician-Assisted Death', Hastings Center Report, 25, pp. 8-17. 27 Jeffrey Blustein (1993), 'Doing What the Patient Orders; Maintaining Integrity in the Doctor-Patient Relationship', Bioethics, 1, pp. 289-314. PARTVI RESEARCH ETHICS 28 Benjamin Freedman (1987), 'Equipoise and the Ethics of Clinical Research', New England Journal of Medicine, 317, pp. 141-45. 29 Philip Pettit (1992), 'Instituting a Research Ethic: Chilling and Cautionary Tales', Bioethics, 6, pp. 89-1 12. 30 Martin Wilkinson and Andrew Moore (1997), 'Inducement in Research', Bioethics, 11, pp. 373-89. 31 P. Lurie and S.M. Wolfe (1997), 'Unelhical Trials of Interventions to Reduce Perinatal Transmission of the Human Immunodeficiency Virus in Developing Countries', New EnglanclJoiirnal ofMedicine. 337, pp. 853-56. 32 Participants in the 2001 Conference on Ethical Aspects of Research in Developing Countries (2004), 'Moral Standards for Research in Developing Countries: From "Reasonable Availability" to "Fair Benefits"', Hastings Center Report. 34. pp. 17-27. PART VII ETHICS AND THE PHARMACEUTICAL INDUSTRY 33 Thomas W. Pogge (2005), 'Human Rights and Global Health: A Research Program', Mefaphilosophy, 36, pp. 182-209. 34 A. Schafer (2004), 'Biomedical Conflicts of Interest: A Defence of the Sequestration Thesis - Learning from the Cases of Nancy Olivieri and David Healy', Journal of Medical Ethics, 30, pp. 8-24. 35 Carl Elliott (2001), 'Pharma Buys a Conscience', American Prospect, 17, pp. 16-20. PART VIII BIOETHICS AND PUBLIC POLICY 36 Daniel Wikler(1999), 'Can We Learn from EwgQmzsT ,Jottrnal of Medical Ethics, 25, pp. 183-94. 37 Judith Jarvis Thomson (1996), 'Abortion', Boston Review, 20, pp. 1-10. 38 Mary Wamock (1987), 'Morality and the Law: Some Problems', Cambrian Law Review, 18, pp. 14-24. 39 Amy Gutmann and Dennis Thompson (1997), 'Deliberating about Bioethics', Hastings Center Report, 27, pp. 38-41,